Irina Bobolea
Overview
Explore the profile of Irina Bobolea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Betancor D, Olaguibel J, Del Pozo V, Alvarez Puebla M, Arismendi E, Barroso B, et al.
Arch Bronconeumol
. 2025 Mar;
PMID: 40087119
No abstract available.
2.
Gonzalez-Barcala F, Bobolea I, Dominguez-Ortega J, Banas-Conejero D, Antelo-Cea E, Martinez-Moragon E, et al.
ERJ Open Res
. 2025 Feb;
11(1).
PMID: 39902267
Introduction: Severe asthma involves a persistent inflammation of the airways that is associated with a greater risk of exacerbations. Exacerbations are associated with a higher lung function decline over time....
3.
Arismendi E, Ribo P, Garcia A, Torrego A, Bobolea I, Casas-Saucedo R, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597790
: Achieving disease control is the main goal in asthmatic patients in order to prevent future risks and exacerbations. There are several clinical guidelines that set different definitions of asthma...
4.
Bobolea I, Hagemann J, Sanak M, Klimek L, Mullol J
J Allergy Clin Immunol Pract
. 2024 Sep;
12(11):2934-2944.
PMID: 39306329
The classic approach of nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (NSAID-ERD) includes pharmaceutical and surgical treatments, as well as avoidance of cyclooxygenase 1-inhibitor NSAIDs. The introduction of biologics in the...
5.
Garriga-Baraut T, Labrador-Horrillo M, Tena M, De Linares C, Esteso-Hontoria O, Pedemonte C, et al.
Allergol Immunopathol (Madr)
. 2024 Jul;
52(4):21-29.
PMID: 38970261
Background: Molecular diagnosis in allergology helps to identify multiple allergenic molecules simultaneously. The use of purified and/or recombinant allergens increases the accuracy of individual sensitization profiles in allergic patients. Objective:...
6.
Lopez-Rodriguez R, Bobolea I, Melero C, Rial M
Front Allergy
. 2024 Feb;
5:1357886.
PMID: 38371921
No abstract available.
7.
Del Pozo V, Bobolea I, Rial M, Espigol-Frigole G, Solans Laque R, Hernandez-Rivas J, et al.
Front Immunol
. 2024 Jan;
14:1310211.
PMID: 38250075
Eosinophil-related diseases represent a group of pathologic conditions with highly heterogeneous clinical presentation and symptoms ranging from mild to critical. Both systemic and localized forms of disease are typically treated...
8.
Valverde-Monge M, Sanchez-Carrasco P, Betancor D, Barroso B, Rodrigo-Munoz J, Mahillo-Fernandez I, et al.
Arch Bronconeumol
. 2023 Dec;
60(1):23-32.
PMID: 38042707
Background: Evaluation of biologic therapy response is vital to monitor its effectiveness. Authors have proposed various response criteria including good responder, super-responder, non-responder, and clinical remission. Objectives: To ascertain the...
9.
Bobolea I, Guillen-Vera D, De Las Cuevas-Moreno N, Garcia-Granero D, Loli-Ausejo D, Melero-Moreno C
Front Allergy
. 2023 Sep;
4:1205115.
PMID: 37744693
Background: The stability of molecular T2/non-T2 phenotypes remains uncertain. The objectives of this study were to assess the stability of these phenotypes and the correlation between serum periostin and asthma...
10.
Romero-Mesones C, Cruz M, Alobid I, Barroso B, Arismendi E, Barranco P, et al.
J Allergy Clin Immunol Pract
. 2023 Jun;
11(11):3407-3413.e1.
PMID: 37391017
Background: Exposure to certain agents in the workplace can trigger occupational asthma or work-exacerbated asthma, both of which come under the heading of work-related asthma (WRA). Understanding the burden that...